the netherlands – Page 11 – Retraction Watch

“Fraud committed by any social psychologist diminishes all social psychologists”: New Sanna, Smeesters retractions

Three new retractions — two of papers by Lawrence Sanna and one of work by Dirk Smeesters — have appeared in the Journal of Experimental Social Psychology. The retractions come along with a hard-hitting piece by the journal’s editor.

In a tough soul-searching editorial called “On Fraud, Deceit, and Ethics” (unfortunately only available behind a paywall), journal editor in chief Joel Cooper writes that “Fraud committed by any social psychologist diminishes all social psychologists.” He continues: Continue reading “Fraud committed by any social psychologist diminishes all social psychologists”: New Sanna, Smeesters retractions

Concern — in triplicate — arrives for Poldermans papers

The Journal of the American College of Cardiology, or JACC, has issued expressions of concern for three papers by Don Poldermans, the Dutch cardiologist who was fired earlier this year amid allegations of misconduct.

Cardiobrief’s Larry Husten had the story first.

The, um, heart of the matter is that neither the investigators at Erasmus Medical Center, Poldermans’ former institution, nor the JACC editors, can say whether the researchers conduct rose to the level of fabricating data. As the Notice of Concern states: Continue reading Concern — in triplicate — arrives for Poldermans papers

“This publication should be ignored”: Authorship issues, flawed data fell neuro-oncology paper

The Journal of Neuro-Oncology wants you to ignore the following paper: “A single chain (scFv425):sTRAIL fusion protein with specificity for the EGF receptor is effective in vitro but not in an in vivo brain tumor animal model.”

The 2007 article, from a group in The Netherlands, suffered from two fatal problems. According to the retraction notice: Continue reading “This publication should be ignored”: Authorship issues, flawed data fell neuro-oncology paper

Odd: Retractions 18 and 19 for Dipak Das, and a new paper in the same journal, as if nothing were amiss

Dipak Das, the resveratrol researcher found guilty of more than 100 counts of misconduct by the University of Connecticut, has two more retractions for his resume. But that’s not the most interesting part of this post, so keep reading after the notices.

Both retractions appeared in the October 2012 issue of the Journal of Cellular and Molecular Medicine. Here’s the first notice: Continue reading Odd: Retractions 18 and 19 for Dipak Das, and a new paper in the same journal, as if nothing were amiss

Double bind: Duplication of bandaging paper leads to retraction

The Journal of Vascular Surgery is retracting — with vigor — a paper it published online in March after discovering that the authors had published essentially the same article for the Journal of the European Academy of Dermatology and Venereology some months earlier.

Both papers are titled “Randomized controlled trial comparing treatment outcome of two compression bandaging systems and standard care without compression in patients with venous leg ulcers.” The work was funded by the Health, Welfare and Food Bureau of Hong Kong and a grant from Lohmann & Rauscher GmbH & Co KG, a German company that makes compression bandages and other surgical supplies.

According to the retraction notice in JVS: Continue reading Double bind: Duplication of bandaging paper leads to retraction

Accounting fraud paper retracted for “misstatement”

The Accounting Review, a publication of the American Accounting Association, has retracted a 2010 paper, but the reason for the move is less than clear.

The article, “A Field Experiment Comparing the Outcomes of Three Fraud Brainstorming Procedures: Nominal Group, Round Robin, and Open Discussion,” was by James E. Hunton, an award-winning accountancy prof at Bentley University in Waltham, Mass., and Anna Gold [updated 1/22/13 to update link], of Erasmus University in Rotterdam, The Netherlands. It has been cited 24 times, according to Google Scholar.

According to the retraction notice: Continue reading Accounting fraud paper retracted for “misstatement”

Intent was there, but not the intention-to-treat analysis: Breast cancer study retracted

A group of Dutch researchers has retracted a paper they published in March after apparently learning that they’d bungled their statistical analysis in the study.